Atlas Trials

Glioblastoma Multiforme (GBM)

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Glioblastoma Multiforme (GBM)

RecordFirmDate
ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme (NCT04587830)Polaris Group2020-09-14
Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma (NCT04019002)Susan Chang2019-11-19
PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma (NCT07120620)Sied Kebir2019-06-25
Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab (NCT01788280)University of Utah2018-01-01
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM (NCT03213002)Northwell Health2017-06-13
Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients (NCT02654041)Musli Thyropeutics Ltd.2016-03-01
TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM (NCT02202993)Cavion, Inc.2014-08-01
CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM (NCT01109095)Baylor College of Medicine2010-10-01
Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA (NCT01238237)Northwell Health2009-12-01

Track Glioblastoma Multiforme (GBM) automatically

Every clearance here is in the API, with alerts when new ones post.